ArticlePloS one2025

FBXW7 metabolic reprogramming inhibits the development of colon cancer by down-regulating the activity of arginine/mToR pathways.

Qing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.